Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Urges caution with diuretic use in HF amid potential drawbacks; leaves open optimal regimens for prospective study.
TRADITIONALLY, nephrologists have focused on a defect in the salt-excreting capacity of the kidney as pivotal to edema formation in heart failure.¹Furthermore, based on the concept of "effective central blood volume," they have argued that the renal response is appropriate to the afferent stimuli impacting the kidney, ie, "relative hypoperfusion of the kidneys." Thus, it seems logical that the first order for therapeutic management of congestive heart failure (CHF) would involve elimination of the excess salt and water contained principally in the extracellular volume (ECV). To accomplish this, pharmacologically active diuretic compounds have been employed with both substantial success and recognized imperfections. One might inquire as to the logic of causing a diureticinduced volume depletion that will cause a fall in cardiac output through a reduction in left ventricular end-diastolic pressure. It would be more logical to either add an ionotropic agent that would improve cardiac performance through
No takes yet. Share an insight, caveat, or question.
George A. Porter (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: